Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy

被引:10
作者
Dong, Ying [1 ]
Gao, Jing [1 ]
Pei, Mengyue [2 ]
Wang, Xiaoli [2 ]
Zhang, Chuangnian [2 ]
Du, Yingjie [1 ]
Jiang, Yanjun [1 ]
机构
[1] Hebei Univ Technol, Sch Chem Engn & Technol, Tianjin 300130, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Biomed Engn, Tianjin Key Lab Biomat Res, Tianjin 300192, Peoples R China
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2020年 / 15卷
基金
中国国家自然科学基金;
关键词
antigen delivery; silica solid sphere; nanovaccine; cancer immunotherapy; MESOPOROUS SILICA; IMMUNE-RESPONSES; DENDRITIC CELLS; BIOCOMPATIBILITY; SIGNALS;
D O I
10.2147/IJN.S242463
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Background: Nanocarriers could deliver significantly higher amounts of antigen to antigenpresenting cells (APCs), which have great potential to stimulate humoral and cellular response in cancer immunotherapy. Thereafter, silica solid nanosphere (SiO2) was prepared, and a model antigen (ovalbumin, OVA) was covalently conjugated on the surface of SiO2 to form nanovaccine (OVA@SiO2). And the application of OVA@SiO2 for cancer immunotherapy was evaluated. Materials and Methods: SiO2 solid nanosphere was prepared by the Stober method, then successively aminated by aminopropyltriethoxysilane and activated with glutaraldehyde. OVA was covalently conjugated on the surface of activated SiO2 to obtain nanovaccine (OVA@SiO2). Dynamic light scattering, scanning electron microscope, and transmission electron microscope were conducted to identify the size distribution, zeta potential and morphology of OVA@SiO2. The OVA loading capacity was investigated by varying glutaraldehyde concentration. The biocompatibility of OVA@SiO2 to DC2.4 and RAW246.7 cells was evaluated by a Cell Counting Kit-8 assay. The uptake of OVA@SiO2 by DC2.4 and its internalization pathway were evaluated in the absence or presence of different inhibitors. The activation and maturation of bone marrow-derived DC cells by OVA@SiO2 were also investigated. Finally, the in vivo transport of OVA@SiO2 and its toxicity to organs were appraised. Results: All results indicated the successful covalent conjugation of OVA on the surface of SiO2. The as-prepared OVA@SiO2 possessed high antigen loading capacity, which had good biocompatibility to APCs and major organs. Besides, OVA@SiO2 facilitated antigen uptake by DC2.4 cells and its cytosolic release. Noteworthily, OVA@SiO2 significantly promoted the maturation of dendritic cells and up-regulation of cytokine secretion by co-administration of adjuvant CpG-ODN. Conclusion: The as-prepared SiO2 shows promising potential for use as an antigen delivery carrier.
引用
收藏
页码:2685 / 2697
页数:13
相关论文
共 36 条
  • [1] Unconventional Maturation of Dendritic Cells Induced by Particles from the Laminated Layer of Larval Echinococcus granulosus
    Casaravilla, Cecilia
    Pittini, Alvaro
    Rueckerl, Dominik
    Seoane, Paula I.
    Jenkins, Stephen J.
    MacDonald, Andrew S.
    Ferreira, Ana M.
    Allen, Judith E.
    Diaz, Alvaro
    [J]. INFECTION AND IMMUNITY, 2014, 82 (08) : 3164 - 3176
  • [2] Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432
  • [3] Mechanically Tunable, Self-Adjuvanting Nanoengineered Polypeptide Particles
    Cui, Jiwei
    De Rose, Robert
    Best, James P.
    Johnston, Angus P. R.
    Alcantara, Sheilajen
    Liang, Kang
    Such, Georgina K.
    Kent, Stephen J.
    Caruso, Frank
    [J]. ADVANCED MATERIALS, 2013, 25 (25) : 3468 - 3472
  • [4] A Multifunctional Nanocarrier Based on Nanogated Mesoporous Silica for Enhanced Tumor-Specific Uptake and Intracellular Delivery
    Gao, Yaohua
    Yang, Cuihong
    Liu, Xue
    Ma, Rujiang
    Kong, Deling
    Shi, Linqi
    [J]. MACROMOLECULAR BIOSCIENCE, 2012, 12 (02) : 251 - 259
  • [5] The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis
    Gerlach, Carmen
    Moseman, E. Ashley
    Loughhead, Scott M.
    Alvarez, David
    Zwijnenburg, Anthonie J.
    Waanders, Lisette
    Garg, Rohit
    de la Torre, Juan C.
    von Andrian, Ulrich H.
    [J]. IMMUNITY, 2016, 45 (06) : 1270 - 1284
  • [6] Tailored Silica Nanomaterials for Immunotherapy
    Gu, Luo
    [J]. ACS CENTRAL SCIENCE, 2018, 4 (05) : 527 - 529
  • [7] Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines
    Hjorto, Gertrud M.
    Larsen, Olav
    Steen, Anne
    Daugvilaite, Viktorija
    Berg, Christian
    Fares, Suzan
    Hansen, Morten
    Ali, Simi
    Rosenkilde, Mette M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [8] The biocompatibility of mesoporous silicates
    Hudson, Sarah P.
    Padera, Robert F.
    Langer, Robert
    Kohane, Daniel S.
    [J]. BIOMATERIALS, 2008, 29 (30) : 4045 - 4055
  • [9] Synthetic Nanoparticles for Vaccines and Immunotherapy
    Irvine, Darrell J.
    Hanson, Melissa C.
    Rakhra, Kavya
    Tokatlian, Talar
    [J]. CHEMICAL REVIEWS, 2015, 115 (19) : 11109 - 11146
  • [10] Kelly PN, 2018, SCIENCE, V359, P1345